ResMed Inc
I · AI-analyse
In het kort
ResMed manufactures devices that help people breathe better during sleep—primarily CPAP machines and other equipment for sleep apnea—and also sells cloud-based software that home health agencies, nursing homes, and medical equipment suppliers use to manage patient records and billing [Yahoo Finance]. They operate in two main segments: Sleep and Breathing Health (the devices) and Residential Care Software (the healthcare management systems).
ResMed is a $30.1 billion medical device company that makes equipment to treat sleep apnea and other breathing disorders, along with software for home healthcare providers [Yahoo Finance]. The company just announced a partnership with Oura, a wearable ring maker, to screen for sleep problems earlier and expand its customer base beyond traditional doctor referrals [Simply Wall St]. Financially, ResMed is exceptionally strong with 27% profit margins, $1.7 billion in free cash flow, and a perfect 10/10 health score [Yahoo Finance] [Sentinellis calculation].
ResMed is in outstanding financial shape with strong profitability, excellent cash generation, and essentially no net debt.
Sentinellis-score
10/10
Financieel gezond
Marktkapitalisatie
$30,1B
Omzet (12 maanden)
$5,1B
Uitleg
Hoe wij deze cijfers lezen
Begrijpelijke gidsen · geen account nodig
ROIC vs WACC Explained: How to Tell If a Company Actually Creates Value
What ROIC and WACC are, how to compute both, and why the spread between them is the single most important number in fundamental investing.
LezenPiotroski F-Score Explained: A 9-Point Financial Health Check (with a Live Apple Example)
What the Piotroski F-Score is, how to calculate all 9 criteria, and how to read the result. Plain English, with a real Apple walkthrough.
LezenAltman Z-Score Explained: Predicting Bankruptcy in 5 Minutes (with Real Examples)
What the Altman Z-Score is, the exact formula, how to read the result, and which version to use for manufacturers vs tech vs private companies.
LezenII · Recent nieuws
Wat de koers bewoog
3 berichten · gesorteerd op relevantie
- Macro2026-05-20
ResMed (RMD) Valuation Check As Oura Sleep Health Collaboration Aims To Expand Sleep Apnea Care Access
Simply Wall St
- Macro2026-05-19
Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference
Yahoo Finance
- Macro2026-05-19
Resmed and ŌURA Partner to Expand Access to Sleep Health Education and Care
Yahoo Finance
Premium · gratis met elk account
The stock has declined nearly 20% over the past three months despite strong fundamentals, indicating investors may be concerned about growth sustainability or competitive pressures not yet visible in the financial data [Simply Wall St].
Risico's
4
Kansen
4
Waarschuwingssignalen
1
Leiding
10
Nog 8 bevindingen in het volledige rapport — gratis met elk account.
Ontgrendel de volledige analyse van ResMed Inc
Maak een gratis account voor het volledige AI-rapport met bronvermelding in de tekst.
- 4 risico's, 4 kansen en 1 waarschuwingssignaal — elk met zijn bron
- Meer dan 100 financiële cijfers met grafieken en vergelijkingen
- Volledige nieuwssamenvattingen met bronlinks
- Directie en beloning
- PDF-export voor offline
III · Vergelijkbare bedrijven
Misschien ook interessant
Zelfde sector · Gezondheidszorg — of vergelijkbare financiële gezondheid
Op je volglijst zetten?